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Abstract 
Using the high efficiency of homologous gene recombination i  Bacillus subtilis, a strategy for mutational nalysis of the proton 
pumping aa3-600 quinol oxidase of this organism has been developed. The qox operon with the qoxA, qoxB, qoxC and qoxD genes, 
coding for the four subunits of this oxidase, was deleted and then replaced with mutated copies in which qoxC (subunit III) or qoxD 
(subunit IV) genes were deleted.The complete deletion of the qox operon caused isappearence of heme aa3-600 and a slight depression 
of the overall respiratory activity, compensated by alternative oxidase with no proton pumping activity. Deletion of qoxC probably 
resulted in a defective assembly of the aa3-600 quinol oxidase. The strain with deletion of qoxD gene expressed normal content of heme 
aa3-600 but exhibited areduced respiratory activity and a significantly depressed proton pumping activity. These results how that subunit 
IV is critical for the activity of the proton pumping aa3-600 quinol oxidase. 
Keywords: Cytochrome; Cytochrome oxidase; Prokaryotic quinol oxidase; (B. subtilis) 
I. Introduction 
The aa3-600 quinol oxidase is one of the terminal 
oxidases of the branched respiratory chain of the aerobic 
Gram-positive Bacillus subtilis. This organism can synthe- 
size a, b, c, d, and o-type cytochromes (for a review see 
Ref. [1]) and at least four terminal oxidases: the caa3-type 
cytochrome-c oxidase, the aa3-600 and d-type quinol 
(menaquinol) oxidases and b and/or o-type oxidase [2-4]. 
The aa3-600 quinol oxidase is predominantly expressed 
during vegetative growth. Cytochrome aa3-600 belongs to 
the superfamily of the heme-copper oxidases and contains 
three active redox centres, two hemes (heme a and a 3) and 
one copper (Cu 8)- The a-band absorption maximum of the 
reduced minus oxidised enzyme is shifted by 5-7 nm to 
the blue, if compared to the majority of the other aa3-type 
oxidases. Like other prokaryotic quinol oxidases [5,6], the 
aa3-600 misses the second copper centre (Cu A) [7], which 
has been demonstrated to be binuclear in Bacillus subtilis 
caa 3 [8]. 
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The aa3-600 quinol oxidase is apparently a four subunit 
enzyme ncoded by the qox operon [9], subunits I, II, III 
and IV being respectively encoded by the genes qoxB, 
qoxA, qoxC and qoxD. 
The catalytic subunit I and subunit III present a high 
degree of similarity with those of bo quinol oxidase of E. 
Coli (cyo operon) [10] and caa3-605 cytochrome-c oxi- 
dase of B. subtilis (cta operon) [9,11] (51% with cyoB and 
48% with ctaD for subunit I, and 45% with cyoC and 
49% with ctaE for subunit III). Subunit II, although with a 
similar hydropathy profile, shows a lower level of amino 
acid identity (31% with cyoA and 25% with ctaC). The 
role of these three subunits, corresponding to the mito- 
chondrial encoded subunits of the eukaryotic ytochrome-c 
oxidase has been largely investigated in prokaryotes. In 
contrast, very little is known on the function of the poorly 
conserved fourth subunit of the bacterial oxidases whose 
sequence is not significantly similar to any nuclear en- 
coded subunit sequence of the eukaryotic enzymes. 
As other members of the heme-copper oxidase super- 
family, the aa3-600 quinol oxidase has a vectorial proton 
translocation activity [12]. Thus, it contributes to the trans- 
membrane lectrochemical gradient by a proton pumping 
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activity (vectorial protons) and a charge separation deriv- 
ing from the anisotropy of the aerobic oxidation of 
menaquinol (scalar protons). 
In this study, using the high efficiency of homologous 
gene recombination in B. subtilis, we have set up a 
strategy for systematic mutational analysis of the aa3-600 
quinol oxidase, based on the use of allelic exchange for the 
insertion of mutations directly on the bacterial chromo- 
some. This strategy mainly consists of two-step gene re- 
placement of the qox operon in the chromosome of B. 
subtilis. The operon is first deleted and then replaced with 
mutated copies in which qoxC (subunit III) and qoxD 
(subunits IV) genes are deleted respectively. 
By using this method, here we show for the first time 
that in B. subtilis subunit IV is critical for the expression 
of a normal proton pumping aa3-600 quinol oxidase and 
that there is an alternative oxidase which does not act as a 
proton pump. 
2. Materials and methods 
2.1. Bacterial strains and growth conditions 
The Bacillus subtilis strain 168 was used as wild-type 
strain. Escherichia coli (E. coli) strains used for the 
plasmid construction and DNA sequencing were the fol- 
lowing: XLl-blue [13], TG1 [14], TP610 [15], TP611 [16]. 
Luria-Bertani (LB) medium was used for standard liquid 
cultures of B.subtilis and E.coli [17]. The minimal salt 
medium (MM) for growth of B. subtilis was that of 
Anagnostopulos and Spizizen [18], supplemented with 0.4% 
glucose as carbon source and tryptophan to a final concen- 
tration of 80 mg/1. Streptomycin resistance of the wild-type 
and mutant strains was tested by growth on sporulation 
(SP) plates [19] containing streptomycin at concentrations 
in the range of 10-100 mg/l .  The following antibiotics 
were used when appropriate: ampicillin 100 mg/1, tetracy- 
clin 20 mg/1, spectinomycin 60 mg/ I  and kanamycin 5
mg/1. 
2.2. DNA methods and genetic techniques 
Transformation of E.coli strains was performed as de- 
scribed by Chung and Miller [20]. B. subtilis cells were 
transformed as described by Anagnostopulos and Spizizen 
[18]. B. subtilis chromosomal DNA was prepared as de- 
scribed by Saunders [21]. Southern blot analysis was per- 
formed using a non-radioactive DNA labelling and detec- 
tion kit from Boehringer Mannheim. Other recombinant 
techniques were performed as described by Sambrook et 
al. [22]. 
2.3. Construction of the mutant strains 
Restriction maps of the plasmids constructed throughout 
this work are shown in Fig. 1. Complete deletion of the 
qox operon was performed using the plasmid pDIA5341 
constructed as follows. The EcoRV fragment of B. subtilis 
chromosomal DNA containing the qox operon with the 
flanking regions was first excised from Lambda sacPT [9] 
and cloned at the unique EcoRV site of pBR322, leading 
to plasmid pDIA5340. The 4.77 kb [kilobase(s)] StuI-NcoI 
fragment was replaced in this last plasmid by the StuI-Ncol 
kanamycin resistant gene from plasmid pDIA5337 [9], 
giving the final construct pDIA5341. Introduction of modi- 
fied copies of the qox operon was performed using plas- 
mids pDIA5342 and pDIA5343. The first one was ob- 
tained by inserting a XbaI-SmaI filled-in spectinomycin 
resistance cassette [23] at the unique StuI site of plasmid 
pDIA5340. The second one was constructed by cloning the 
EcoRV fragment from pDIA5342 in pUC19 digested by 
HindlII-EcoRI filled-in with Klenow. 
Deletion of the qoxD gene was obtained by excising a 
NcoI fragment of 296bp [base pair(s)], containing the 
almost complete gene, from pDIA5342, the resulting con- 
struct being named pDIA5345. 
Deletion of the qoxC gene in pDIA5343 was obtained 
in two steps. In a first step, a SphI-SspI fragment of 0.6 kb 
was subcloned in pUC19 digested by SphI and HinclI. In 
the second step, the RsrI I-EcoRI fragment from pDIA5343 
was replaced by the truncated RsrlI-EcoRI fragment from 
this intermediate construction, leading to a 0.4 kb SspI- 
EcoRI deletion in pDIA5343. The final construct was 
called pDIA5344. The almost complete deletion of the 
qoxC gene was obtained and a new stop codon, 138 bp 
upstream the initiation codon of the following qoxD gene, 
was created. In this way the translation initiation site of the 
qoxD gene should be unaffected by the mutation. 
The strain bringing the complete deletion of the qox 
operon, named Aqox, was obtained by transformation of
B. subtilis with linearized plasmid pDIA5341 and by 
selection for kanamycin resistance. B.s. 168::SpecR, AqoxC 
and AqoxD strains were obtained by transformation f the 
Aqox strain with linearized plasmids pDIA5343, pDIA5344 
and pDIA5345 respectively and by selection for spectino- 
mycin resistance (the kanamycin sensitivity being restored). 
The exact gene replacement was checked in all the mutant 
strains by Southern blot (data not shown). 
2.4. Preparation of solubilized membranes 
B. subtilis wild-type and mutant strains were grown in 
2-1itre flasks at 37°C. For the mutant strains, overnight 
precultures were made in the presence of the required 
antibiotics, whereas the large volume cultures were per- 
formed without antibiotics to avoid interference in the 
growth. The bacterial cells were harvested during the 
exponential phase (turbidity at 600 nm = 0.7-0 .90.D. )  
and membranes were essentially prepared as in [4] except 
that a higher ratio protein/Triton X-100 (0.37 w/w)  was 
used for the solubilization step. 
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Fig. 1. Restriction map of the inserts of the constructed plasmids. D, DrallI; E, EcoRl; K, Kpnl; N, Ncol; R, RsrlI; Sp, SphI; Ss, SSpI; St, StuI; V, 
EcoRV; kanR and spcR refer to kanamycin and spectinomycin resistance genes, respectively. Term. indicates transcription termination sequence. Genes 
are represented by arrows. Lost restriction sites are indicated in brackets. For details see Section 2. 
2.5. Optical spectroscopy 
Liquid nitrogen temperature spectra were essentially 
performed as in [9], except that no artificial reductant was 
added in the sample. In the condition used the sample is 
assumed to be in anareobiosis with the hemes reduced by 
endogenous substrates. 
In the difference spectra on solubilized membranes, the 
heroes c and b contents were estimated, deconvoluting the 
contributions of both heroes to the absorbance at their 
specific maxima in the region 550-535 nm and 558-575 
nm respectively. The extinction coefficients used were 
Ae558_575--- 16.9 mM - j ,  Ae550_535 =5.5  mM -I for cy- 
tochrome b [7] and Ae558_575 = 2.9 mM - l ,  Aess 0 535 = 
23.97 mM-  ~ for cytochrome c [24] and the concentrations 
calculated by the following equations: 
[cyt. b] = 0.062 × A558 575 - 0.008 × AA550_535 
[cyt. c] = 0.420 × A550_535 - 0.229 × [cyt. b] 
Heme a + a 3 content was measured from AA at 600-630 
nm eventually corrected for baseline slope using a Ae = 
13.3 mM i [7]. 
2.6. Measurements of redox-linked proton translocation 
and 02 consumption 
Proton translocation was measured electrometrically by 
the oxygen pulse method. 50 ml of cell at the log growth 
phase (turbidity at 600 nm= 0 .7 -0 .90 .D . )  were cen- 
trifuged and the pellet resuspended in 0.2 ml of the assay 
medium. 0.1 ml of this cell suspension were added to 3.1 
ml of 50 mM KCI, 100 mM KSCN, 0.5 mM Hepes (pH 
7.4), in a stoppered glass vessel equipped with a Clark-type 
oxygen electrode and a fast responding pH electrode. The 
suspension was thermostated at 25°C and vigorously stirred. 
The oxygen uptake by endogenous respiration was moni- 
tored until full anaerobiosis was achieved; after 5 min 
equilibration the pH of the suspension was 6.5-6.7 and 
proton release was elicited by adding 2.5 /zM 0 2 as 
air-equilibrated bidistilled water at 25°C. pH changes were 
quantitated by titrated 10 mM HC1 additions. 
For oxygen consumption measurements, the harvested 
cells were resuspended to and OD600 of 10 in LB (Luria- 
Bertani) medium. 50 /zM of this cell suspension were 
added to 1.6 ml of the same medium and the respiration 
monitored polarographically. All the assays were repeated 
several times and results were found to be reproducible 
within 10%. 
For the inhibitor-titration, HOQNO or KCN were added 
when a stationary respiratory rate was achieved and the 
inhibited respiratory rate was also measured under station- 
ary conditions (5 min after the addition of the inhibitor); 
this was critical in particular for KCN inhibition at subsat- 
urating concentrations for some of the mutant strains tested, 
where a sluggish phase was observed (see text and Fig. 6). 
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The I20 was calculated best fitting the respiratory rates vs 
the inhibitor concentrations plot by the following empirical 
equation: 
V, /V  o = 1 -- [1 ] " / ( [ I ] "  +150 ) 
where: V 1 = respiratory rate at a given inhibitor concentra- 
tion; V o = uninhibited respiratory rate; [I] = concentration 
of the inhibitor; n = exponential factor; /5o = concentration 
of the inhibitor giving 50% inhibition. 
3. Resu l ts  
The strategy of mutagenesis schematically presented 
in Fig. 2. It consists mainly of a two-step gene replacement 
method, employing spectinomycin (specR) and kanamycin 
(kanR) resistance genes as selective markers. In the first 
step (deletion step) the complete qox operon was removed 
from the chromosome of B. subtilis and replaced by the 
kanR gene. In the second step, a modified copy of the qox 
operon flanked by the specR gene was introduced in the 
chromosome of the Aqox strain, replacing the kanR gene. 
The position of the specR gene was chosen in order not to 
affect the expression of the qox operon. However, this 
marker interrupts the upstream ipa-36d gene, presumed to 
code for a galactose l-p uridyltransferase [16]. Comparison 
of the wild type strain and the mutant strain B.s. 168::SpecR 
(carrying only the insertion of the specR gene in the 
chromosome) showed no difference as far as shape of 
colonies, streptomycin resistance, spectra and other bio- 
chemical parameters tested in this work, are concerned. By 
using this method the mutant strains Aqox, AqoxC and 
AqoxD, harbouring deletion of the whole qox operon, of 
the qoxC gene and qoxD gene respectively, were con- 
structed. 
Since the streptomycin resistance has been largely used 
to isolate strains carrying mutations affecting cytochrome 
aa 3 in B. subtilis [25,26], we tested our mutant strains on 
plates containing streptomycin (see Table 1). The mutant 
strain Aqox showed in fact a strong resistance to this 
antibiotic, confirming the previous results on mutants lack- 
ing aa3-type cytochromes [26,27] and, in particular, on the 
B. subtilis strain where the qox operon had been inter- 
rupted [9]. The streptomycin sensitivity was partially re- 
stored in the AqoxC mutant, whereas no reversion was 
observed in the strain AqoxD (resistant up to 100 mg/ l  of 
streptomycin). 
The low-temperature absolute spectrum of intact cells 
of the B. subtilis 168 wild-type strain shows the a-band 
absorption maximum at ~- 600 nm and T-band shoulder at 
= 440 nm, characteristic of the reduced cytochrome aa 3 
of quinol oxidase in this species, evidently kept reduced by 
endogenous ubstrates (Fig. 3). Both the a-peak and 3,_ 
shoulder of cytochrome aa 3 were absent in the Aqox 
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kanR 
/ / / / / / / / /~  pDIA5341 
=. . .  qox  operon 
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"/////////A 
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plasmids with mutated copies 
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Fig. 2. Strategy of mutagenesis. U and D refer to the upstream and downstream regions of the qox operon coding for the aa3-600 quinol oxidase; kanR 
and specR refer to the kanamycin and spectinomycin resistance g nes respectively. Crossed lines indicate asingle crossing-over event. 
Table 1 
Phenotypes of Bacillus subtilis strains 
550 558 
B.s. 168 Aqox AqoxC AqoxD 
Heme a ~ 0.35 n.d. 0.13 0.35 
Heme b ~ 0.71 0.58 0.62 0.51 
Heme c a n.d. f 0.19 n.d. 0.18 
02 consumption b 182+6 125+7 299+8 88___5 
KCN c 35 177 395 76 
HOQNO c 0.07 0.4 1.0 1.0 
H +/e -  2.0 1.0 0.9 1.2 
Power output J 364 125 269 106 
Strep. res. e _ + + + + + + 
Heine contents in the membranes, treptomycin resistance, respiratory 
activity, H+/e  - for respiration-linked proton ejection and sensitivity of 
respiration to inhibition by KCN and HOQNO (for more details see 
Section 2). 
nmol of heme/mg membrane proteins; b/LM e-/min/OD600; c 150 as 
/zM concentration; d/xM H+/min/O.D.6o0; e streptomycin resistance 
tested in a range of 10-100 rag/l; f not detectable. 
mutant in which the operon was completely deleted. Dele- 
tion of the qoxC gene (subunit III) or of the qoxD gene 
(subunit IV) had no detectable effect on the position of the 
c~-peak and y-shoulder of reduced cytochrome aa 3 of 
quinol oxidase in intact cells (Fig. 3). This spectroscopic 
pattern was confirmed by difference (reduced-minus- 
oxidised) spectra of solubilized membranes showing in the 
wild type strain, AqoxC and AqoxD mutants the differ- 
ence c~-peak at 600 nm of cytochrome aa 3 (Fig. 4). 
Difference spectra showed also, in the wild-type and mu- 
tant strains a large absorption peak at 556-568 nm typical 
of b cytochrome (Figs. 3 and 4). Occurrence in Bacillus 
subtilis cytoplasmic membrane of a cytochrome b-558 of 
succinate-menaquinone reductase [27,28] and of different 
b-type cytochromes which bind carbon monoxide and could 
represent alternative oxidases has been reported [2,3] (see 
however Ref. [12]). In Fig. 5 CO-reduced minus reduced 
difference spectra for the wild-type strain and the Aqox 
mutant are presented. The positive contribution of heme a 
type at 430 and 590 nm and the negative contribution at 
444 nm visible in the wild-type are absent in the Aqox 
6~ B.s. 168 
AA0.04[ ~ ~  AqoxD 
tS0 irltTi I
Fig. 3. Absolute spectra of B. subtilis strains. Spectra were recorded at 
liquid nitrogen temperature on whole-cell suspension. 
11 
,'tA =~0.005 
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Fig. 4. Difference optical spectra of solubilized membranes from wild-type 
and mutant strains of B. subtilis. Membranes were prepared as described 
in Section 2 and suspended in "Iris [Tris(hydroxymethyl)-methylamine]- 
HCI 50 mM (pH 8.0), NaC1 150 mM, 3% Triton X-100, at a protein 
concentration of 1-1.5 mg/ml. The spectra were scanned at room 
temperature with the reference sample oxidised by 0.1 mM ferricyanide 
and the measure sample reduced by a few grains of dithionite. 
mutant. Positive contribution of heme b type at 418 nm 
and negative contribution at 428 and 558 are clearly 
visible both in the wild and Aqox strains. 
Deconvolution of difference spectra revealed the ap- 
pearance of a detectable amount of cytochrome c in the 
418 43~44 55X 5~1 
ii i : ~qox 
8 
400 450 500 550 600 650 
rim 
Fig. 5. CO-reduced minus reduced difference spectra of B. subtilis 
membranes. Membranes from wild type and Aqox strains were prepared 
as reported in Section 2 and suspended in the medium described in Fig. 4 
to a final concentration of 2 mg prot/ml. The reduced form of the 
membraneous cytochromes was obtained by addition of a few grains of 
Na2S204 and the room-temperature spectra stored in the memory of a 
diode array spectrophotometer; hen CO was bubbled through the suspen- 
sion, supplemented with a small amount of antifoam, for 2 rain in the 
dark, the CO-reduced spectra taken and the stored reduced spectra 
subtracted from it. The CO-reduced species were spectrally stable for at 
least one hour. 
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Fig. 6. Redox-linked proton translocation measured in cells of wild-type 
and mutant strains of B. subtilis. For experimental conditions ee Section 
2. The figures on the curves refer to the t~/2 of the proton backflow 
following the initial release (see text). 
strains Aqox and AqoxD (Table 1); this was also con- 
firmed by ascorbate reduced-minus-oxidised spectra on 
solubilized membranes (data not shown). 
It should be noted that, under the exponential growth 
conditions used, no spectroscopic signal of the d-type 
cytochrome (showing an absorption maximum at about 
630 nm) was observed either in the wild-type or in the 
mutant strains. 
The respiratory proton pumping activity of B. subtilis 
strains was examined by oxygen pulses of freshly har- 
vested log-phase cells resuspended in a KSCN-KC1 medium 
made anaerobic by endogenous respiration (Fig. 6). As 
shown by Lauraeus and WikstrtSm [12], in the wild-type 
strain of B. subtilis, oxygen pulses resulted in proton 
ejection with an H+/e  - (ratio of protons translocated per 
electron transferred to dioxygen) of 2, due to the activity 
of the aa3-600 quinol oxidase. Bacillus subtilis expresses, 
apparently, only a NADH-quinone oxidoreductase which 
does not pump protons [12]. It has to be recalled that 
oxidation of hydrogenated carriers (menaquinol) by cy- 
tochromes takes place at the outer side of the plasma 
membranes so as to result directly in the scalar elease of 1 
H+/e  -. The additional proton release is contributed by 
vectorial proton pumping from the cytoplasmic to the 
external medium, this amounting in the wild-type strain to 
1 H+/e  [12]. The Table summarizes the H+/e  ratios 
expressing the overall proton pumping capacity of the 
respiratory chains of the B. subtilis strains (see also Fig. 
6), the respiratory activities, the content of cytochromes 
and the concentrations of KCN and HOQNO [(2-heptyl-4- 
hydroxyquinoline), classical inhibitor of quinol oxidases] 
giving 50% inhibition of respiration. 
The complete deletion of the qox operon (Aqox strain), 
resulting in disappearance of cytochrome aa 3 (Figs. 3 and 
4), exhibited only a small depression of respiratory activ- 
ity, no significant change in the content of b cytochromes, 
appearance of cytochrome c, full suppression of vectorial 
proton pumping (only scalar release of 1 H+/e  - was in 
fact detected in this strain). The depression of proton 
pumping observed in the Aqox and other B. subtilis 
mutants did not result from enhanced rate of passive 
proton back-flow. Indeed, the t~/2 for proton re-entry 
observed upon anaerobiosis was practically the same in all 
the mutants as compared to the wild-type strain. The 
sensitivity to the respiratory inhibitors KCN and HOQNO 
was significantly decreased. 
In the AqoxC (subunit III deficient) strain, the amount 
of cytochrome aa3-600 detected in the solubilized mem- 
branes was about one-third of that in the wild-type strain, 
the content of b-type cytochromes was practically un- 
changed as compared to the wild-type strain and no cy- 
tochrome c was apparently expressed. The respiratory 
activity was much larger not only as compared to the 
Aqox, but also to the wild-type strain. No vectorial proton 
pumping was, however, associated with this respiratory 
activity which, on the other hand, exhibited a decreased 
sensitivity to inhibition by KCN and HOQNO also as 
compared to the Aqox strain. 
In the AqoxD (subunit IV-deficient) strain, the mem- 
brane presented a normal amount of cytochrome aa3-600, 
decreased level of b cytochromes as compared to the 
wild-type strain and a substantial content of cytochrome c. 
The respiratory activity was, however, markedly de- 
pressed, even below that of Zlqox strain and exhibited a 
decreased sensitivity to inhibition by HOQNO. In the 
AqoxD strain the efficiency of respiratory proton pumping 
was decreased to an H+/e  - ratio of 1.2. 
Another anomalous feature of the respiratory activity of 
the Aqox, AqoxC and AqoxD mutant strains was repre- 
sented by a pronounced lag in inhibition by KeN as 
compared to the wild-type strain, where respiration was 
immediately blocked upon addition of the inhibitor (Fig. 
7). 
A qoxC 
250/JM / 
K C 7  B.s.168 
/~  A qox 
oo, ,s /Y/   qoxo < 
I 27/JM 02 consumption 
mig 
Fig. 7. Oxygen consumption and cyanide inhibition in cells of wild-type 
and mutant strains of B. subtilis. For experimental conditions ee Section 
2. 
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4. Discussion 
Taking advantage of the homologous gene recombina- 
tion in Bacillus subtilis, we have developed in this work 
an efficient tool for mutational analysis of the aa3-600 
quinol oxidase. This is based on a two-step gene replace- 
ment method and utilizes antibiotic resistance genes as 
selective markers. It allows to introduce deletions or site- 
directed mutations in the qox operon directly in the chro- 
mosome, so representing a less disputable alternative to the 
usual complementation technique so far applied for the 
mutational analysis of bacterial cytochrome oxidases [29]. 
Performing mutagenesis on the chromosomal copy version 
of a gene, instead of using a plasmid-borne copy, leads to 
several advantages for structural and physiological analy- 
sis: (i) stability of the DNA constructs within the cells; (ii) 
expression of the mutated operon at physiological levels; 
(iii) respect of the normal internal stoichiometry of the 
subunits encoded by the operon. Our strategy is evidently 
made possible by the fact that the aa3-600 quinol oxidase 
is not essential for the growth of B. subtilis. This Gram- 
positive bacterium has in fact a branched respiratory chain 
with at least four terminal oxidases. 
The low temperature absolute spectra of intact cells and 
differential (reduced-minus-oxidised) spectra of solubilized 
membranes show that, under the growth conditions used in 
our experiments (exponential phase in a rich medium), the 
B. subtilis 168 strain expresses the aa3-600 quinol oxidase, 
but not the caa3-605 oxidase, neither the d-type oxidase. 
The absence of any cytochrome-c oxidase activity was 
confirmed by the finding that cyanide-sensitive respiration 
supported by ascorbate plus TMPD (N,N,N'N'-tetra- 
methyl-p-phenylendiamine) was negligible both in the wild 
and in the mutant strains (data not shown). The wild-type 
strain seems also to express b-type CO-binding cy- 
tochromes (see Figs. 3-5); however, the KCN-titration of 
the respiratory activity of the cells, giving an I50 typical of 
the a-type oxidases, indicates that b-type cytochromes 
should be inactive in the wild-type strain. 
Spectroscopic and functional characterization f the B. 
subtilis mutant Aqox shows that deletion of the qox 
operon results in the expected disappearance of cy- 
tochrome aa3-600 quinol oxidase. The overall respiratory 
activity of the mutant was, however, compensated by the 
alternative oxidase of the b-type (or o-type). The respira- 
tory activity in this mutant had a diminished sensitivity to 
KCN (this confirming previous results [2,3]) and to HO- 
QNO; it exhibited only scalar H ÷ release (i H+/e  - )  
associated to oxidation of endogenous hydrogen carrier 
(menaquinol) with no outward proton pumping. Thus the 
putative b-type oxidase of B. subtilis, at least in the Aqox, 
as well as in the AqoxC and AqoxD mutants, where it 
might be activated, does not pump protons. 
It is worth noting that the overall pumping activity of 
the B. subtilis strains, expressed as the product of the 
respiratory activity and the H+/e  ratio, is inversely 
related to the streptomycin resistance of the strains (see 
Table 1). Thus the Aqox and AqoxD strains, which 
exhibit the lowest power output for proton pumping, are 
those showing higher resistance to this antibiotic. It might 
be noted that these strains also show the same phenotype 
as far as shape of colonies (smaller than the wild-type) and 
content of cytochrome c are concerned. 
Phenotypic characterization of the B. subtilis mutant 
obtained by replacement of the qox operon with the 
mutated copy of the operon-harbouring specific deletion of 
the qoxC gene may indicate that subunit III, encoded by 
this gene, is essential for the proper assembly of a func- 
tional, proton pumping aa3-600 quinol oxidase. The re- 
duced content of the cytochrome aa3-600 in the membrane 
could result from a defective association with the mem- 
brane of subunit I and maybe of subunits II and IV. 
Evidence that deletion of subunit III leads to defective 
assembly of cytochrome-c oxidase in Paracoccus denitrif- 
icans has also been reported [30,31]. The AqoxC mutant 
of B. subtilis exhibits, in fact, a respiratory activity which 
is even larger than that of the wild-type strain. Since no 
expression of cytochrome d and caa3-605 could be de- 
tected even in this mutant, it seems possible that the higher 
respiratory rate, which has a diminished sensitivity to KCN 
and HOQNO, even as compared to the Aqox strain, and 
does not result in proton pumping (as revealed by an 
overall proton translocation of 1 H+/e - ) ,  represents an 
increased activity of alternative oxidase and/or an anoma- 
lous activity of improperly membrane-assembled subunits 
I, II and may be IV of the aa3-600 oxidase. However, this 
residual activity of the subunit Ill-depleted enzyme should 
still maintain anisotropy of menaquinol oxidation, as indi- 
cated by the release of 1 H+/e - .  
Deletion of the qoxD gene (subunit IV) did not affect 
the content of cytochrome aa3-600 in the membrane. The 
respiratory activity of this mutant was, however, impaired 
and its sensitivity to HOQNO, and to some extent also to 
KCN, was decreased. Proton pumping in the AqoxD strain 
was largely suppressed, as indicated by the lower sto- 
icheiometry of the total proton ejection (1.2 H+/e  -). This 
could be due to greater contribution to the overall respira- 
tory activity of the alternative b-type oxidase and/or 
decoupling of proton pump in the defective nzyme. In any 
event the observations show that subunit IV is essential for 
the functional activity of the proton pumping aa3-600 
quinol oxidase of Bacillus subtilis. 
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